- About Us
- Advertise
- Contact Us
- Editorial Info
- Editorial Contacts
- Editorial Advisory Board
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2023 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Pharmaceutical Technology, April 2023
Balancing Change and Certainty in Manufacturing
April 03, 2023
Focus
47
4
As new manufacturing processes and technologies are introduced to meet demand and overcome challenges, understanding also needs to improve to ensure the right balance is achieved.
Formulating Drugs for Continuous Processing
April 03, 2023
Development
47
4
Despite the advantages intensified processes can offer developers, there are still some obstacles to overcome before broader application of new technologies will be implemented.
Quality Challenges Associated with Cryo/Lyoprotectants
April 03, 2023
Development
47
4
Impurities and batch-to-batch variability present the biggest challenges.
Small Footprint Automated Closed Production Platforms for CAR-T and Other Advanced Therapies
April 03, 2023
Manufacturing
47
4
Limitations in production platforms have impeded continuous manufacturing for advanced therapies.
Packaging Becomes More Sustainable
April 03, 2023
Manufacturing
47
4
Manufacturers and suppliers join forces to reduce the pharmaceutical industry’s carbon footprint.
Accepting Alternative Approaches to Freeze Drying
April 02, 2023
Manufacturing
47
4
Alternative approaches to freeze-drying are gaining popularity and will help to overcome some of the challenges associated with conventional lyophilization.
Considerations for Analytical Testing for E&L
April 02, 2023
Analytics
47
4
Considering the differences between small- and large-molecule drug products can help determine analytical testing methods for E&L.
Contract Testing Services Solidify Their Place in the Manufacturing Value Chain
April 02, 2023
Outsourcing
47
4
Contract testing services demonstrate a major increase in the speed and efficiency of testing using new testing methods and technologies.
A New Hope for Children Living with HIV
April 02, 2023
Biotech business
47
4
New child-friendly treatment options and initiatives are improving the outlook of children living with HIV in Europe.
Kudos and Hurdles in Tackling Rare Diseases
April 02, 2023
Regulatory Watch
47
4
FDA has spurred investment to create and develop 600 therapies.
Changes Afoot in Pharmaceutical Laws and Regulations in Spain
April 02, 2023
Regulatory Watch
47
4
Proposed regulatory changes signal a major overhaul of legislation governing pharmaceuticals and healthcare in Spain.
The Relationship Between CAPAs and Data: What’s the Right Balance?
April 02, 2023
Ask the Expert
47
4
A risk assessment should be performed as part of the CAPA process, says Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates.
Zauberkugel: Pfizer’s Seagen Acquisition
April 02, 2023
From The Editor
47
4
What can we take away from Pfifzer's acquisition of Seagen?
Legislative Hold-Up
April 02, 2023
From The Editor
47
4
A further setback to the publication of the pharmaceutical legislative changes in Europe may mean time is running out for appropriate review before 2024 parliamentary elections.
Who’s Got Game?
April 02, 2023
From the CEO
47
4
Direct-to-consumer drug advertising has developed as a cottage industry which has been used to increase prescriptions immensely.